Isoleucine
Who holds supplier records for Isoleucine? 11 organisations hold a current record for Isoleucine: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (5), Japan (2), Germany (1) and Brazil (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Isoleucine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/isoleucine
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Isoleucine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AMINO GMBHGermanyCEP Company GMP cert on recordActive DMF 4041 · latest filing Oct 1980
- AJINOMOTO DO BRASIL INDUSTRIA E COMERCIO DE ALIMENTOS LTDABrazilActive DMF 21991 · latest filing Jul 2008
- MIANYANG SHENGSHI HEALTH TECHNOLOGY CO LTDActive DMF 42973 · latest filing Nov 2025
- SHANGHAI AJINOMOTO AMINO ACID CO LTDChinaActive DMF 29143 · latest filing Feb 2015
- JapanCEP Company GMP cert on record
- EVONIK REXIM NANNING PHARMACEUTICAL CO LTDCEP
- JapanCEP
- Shanghai Plumino Amino Acid Co.,Ltd.ChinaCEP Company GMP cert on record
- ChinaCEP
- WUXI JINGHAI AMINO ACID CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Isoleucine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| AJINOMOTO CO., INC. Chuo-Ku | JP | CEP 2009-100 - Rev 01 Isoleucine, Limeira Amino Acid site | Aug 2026 | — |
| SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai | CN | CEP 2010-188 - Rev 01 Isoleucine | Oct 2025 | Inspected Mar 2024 Germany |
| WUXI JINGHAI AMINO ACID CO., LTD. Donggang Town | CN | CEP 2018-019 - Rev 01 Isoleucine | Mar 2024 | — |
| YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD. Yichang | CN | CEP 2023-047 - Rev 00 Isoleucine | Dec 2023 | — |
| EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning | CN | CEP 2008-098 - Rev 02 Isoleucine | Oct 2023 | — |
| TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin | CN | R0-CEP 2020-206 - Rev 00 Isoleucine | Oct 2022 | — |
| AMINO GMBH Frellstedt | DE | R1-CEP 2004-228 - Rev 03 Isoleucine, From Fermentation | Jun 2021 | — |
| KYOWA HAKKO BIO CO., LTD. Tokyo | JP | R1-CEP 1999-014 - Rev 04 Isoleucine | Aug 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Isoleucine are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- SIGMA F AND D DIV LTDInactive DMF 9991 · filed Nov 1992
- TANABE SEIYAKU CO LTDInactive DMF 1250, 9422 · filed Nov 1991
- DEGUSSA AG WERK RADEBEULInactive DMF 4019 · filed Nov 1980
- KYOWA HAKKO USA INCInactive DMF 2623 · filed Feb 1976
Overview
Isoleucine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1233584).
Chemical identity
- IUPAC name
- (2S,3S)-2-amino-3-methylpentanoic acid
- Canonical SMILES
- CC[C@H](C)[C@@H](C(=O)O)N
- InChIKey
- AGPKZVBTJJNPAG-WHFBIAKZSA-N
- Synonyms
- FEMA NO. 4675, ILE, Isoleucina, Isoleucine, L-isoleucine, NSC-46708, (2S,3S)-2-Amino-3-methylpentanoic acid, 2S,3S-Isoleucine, (S)-Isoleucine, (S,S)-Isoleucine, 2-Amino-3-methylvaleric acid, erythro-L-Isoleucine
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Isoleucine?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Isoleucine: AMINO GMBH (Germany), AJINOMOTO DO BRASIL INDUSTRIA E COMERCIO DE ALIMENTOS LTDA (Brazil), MIANYANG SHENGSHI HEALTH TECHNOLOGY CO LTD, SHANGHAI AJINOMOTO AMINO ACID CO LTD (China), AJINOMOTO CO INC (Japan), EVONIK REXIM NANNING PHARMACEUTICAL CO LTD, Kyowa Hakko Bio Co., Ltd. (Japan) and Shanghai Plumino Amino Acid Co.,Ltd. (China), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Isoleucine Drug Master Files are active?
AMINO GMBH (DMF 4041), AJINOMOTO DO BRASIL INDUSTRIA E COMERCIO DE ALIMENTOS LTDA (DMF 21991), MIANYANG SHENGSHI HEALTH TECHNOLOGY CO LTD (DMF 42973) and SHANGHAI AJINOMOTO AMINO ACID CO LTD (DMF 29143). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Isoleucine records mean?
4 organisations have only inactive Type II DMFs for Isoleucine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Isoleucine have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Isoleucine on the EDQM register, including AJINOMOTO CO., INC. Chuo-Ku (JP), SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai (CN), WUXI JINGHAI AMINO ACID CO., LTD. Donggang Town (CN), YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD. Yichang (CN), EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning (CN) and TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin (CN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Isoleucine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Isoleucine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.